Evidence-based clinical review The Neurology of Dysautonomia POTS, Orthostatic Intolerance, and Autonomic Testing in 2026 A Practical Neurologic Framework for Distinguishing POTS From Other Orthostatic Syndromes and Selecting Active Stand, Tilt-Table, Reflex, Sudomotor, and Small-Fiber Studies Estimated reading time: 15 minutes
Tag: neurology
Posterior Cortical Atrophy, Primary Progressive Aphasia, and the Non-Amnestic Alzheimer’s Patient
Posterior Cortical Atrophy, Primary Progressive Aphasia, and the Non-Amnestic Alzheimer's Patient Review Abstract Alzheimer's disease is often marked by progressive episodic memory loss, but not all patients start with an amnestic syndrome. Some patients may initially present with issues in visual-spatial skills, language, executive function,
Frontotemporal Dementia After the Bruce Willis Effect: What Neurologists Should Revisit
Frontotemporal Dementia After the Bruce Willis Effect What Neurologists Should Revisit Review Abstract The public disclosure of a frontotemporal dementia diagnosis by Bruce Willis brought unprecedented public attention to a neurodegenerative disorder that has historically remained underrecognized outside specialized neurology and memory clinics. While increased awareness has
Lecanemab in Real-World Practice: What Early Alzheimer’s Patients Are Actually Experiencing
Lecanemab in Real-World Practice: What Early Alzheimer’s Patients Are Actually Experiencing Review Abstract Lecanemab represents a major milestone in the treatment of Alzheimer’s disease as the first anti amyloid monoclonal antibody to receive traditional approval from the United States Food and Drug Administration for patients with early
Plasma Biomarkers for Neurodegenerative Disease: What Clinicians Need to Know in 2026
Plasma Biomarkers for Neurodegenerative Disease What Clinicians Need to Know in 2026 Review Key Takeaways Plasma biomarkers are rapidly transforming the diagnosis and management of Alzheimer’s disease and related dementias, representing one of the most notable advances in neurodegenerative medicine in recent decades. Historically, the definitive assessment of Alzheimer’s pathology has
Cerebral Small Vessel Disease: The Hidden Driver of Cognitive Decline
Cerebral Small Vessel Disease: The Hidden Driver of Cognitive Decline Review Abstract Cerebral small vessel disease (CSVD) represents one of the most common yet underrecognized causes of cognitive impairment and functional decline worldwide. The condition affects the brain’s smallest blood vessels and leads to a
Neuroethics of Cognitive Enhancement: Where Should Neurologists Draw the Line?
Neuroethics of Cognitive Enhancement: Where Should Neurologists Draw the Line? Check out our extensive video library (see channel for our latest videos) Abstract The rapid evolution of cognitive enhancement technologies presents neurologists and other healthcare professionals with increasingly complex ethical challenges. These challenges extend
How Deep Brain Stimulation Repairs Neural Pathways to End the Addiction Cycle
How Deep Brain Stimulation Repairs Neural Pathways to End the Addiction Cycle Please like and subscribe if you enjoyed this video :-) Introduction Drug addiction causes 11.8 million deaths each year, surpassing all cancer deaths combined. It has prompted experts to research other treatment modalities
Intracranial Aneurysm And Gut Health
Intracranial Aneurysm And Gut Health Intracranial aneurysm (IA) is a pathological dilation of the intracranial artery wall, most commonly occurring in the circle of Willis, with an incidence rate of around 3% in the general population. While unruptured IAs (UIAs) are often asymptomatic, the rupture of an aneurysm leads
Alzheimer’s Disease Revealed By Reliable Digital Memory Assessments
Alzheimer's Disease Revealed By Reliable Digital Memory Assessments Alzheimer's disease (AD) research has advanced in detecting pathological changes through biomarkers, but cognitive measures lag in capturing early, subtle impairments. Traditional assessments designed for overt deficits are now outpaced by discoveries in episodic memory networks within the medial temporal lobe, which are
